Overview of Multiplex Immunohistochemistry and Immunofluorescence Techniques 
in the Lung Cancer Immunotherapy by Wenjia SUN, Jianya ZHOU, Jianying ZHOU

Get full text

Advances in Diagnosis and Targeted Therapy of G719X/L861Q/S768I Mutant 
Non-small Cell Lung Cancer by Yufang WANG, Jing ZHENG, Yanping ZHU, Jianya ZHOU

Get full text

Progress on the Study of PD-L1 Detection Methods in Non-small Cell Lung Cancer by Xuejing GUO, He CAO, Jianya ZHOU, Jianying ZHOU

Get full text

Clinical Characteristics, Co-Mutations, and Treatment Outcomes in Advanced Non-Small-Cell Lung Cancer Patients With the BRAF-V600E Mutation by Jingjing Qu, Jingjing Qu, Qian Shen, Qian Shen, Yuping Li, Farhin Shaheed Kalyani, Li Liu, Jianya Zhou, Jianya Zhou, Jianying Zhou, Jianying Zhou

Get full text

Advances in Diagnosis and Treatment of HER2-positive Non-small Cell Lung Cancer by Chenyi REN, He CAO, Jing ZHENG, Wenjia SUN, Jianya ZHOU

Get full text

Prognostic Analysis of EGFR-TKIs Combined with Gamma Knife in EGFR-mutant Lung Adenocarcinoma with Brain Metastasis by Limin CHEN, Mengjiao FU, Jianya ZHOU, Yinan YAO, Jianying ZHOU

Get full text

Driver Genes Associated With the Incidence of Venous Thromboembolism in Patients With Non-Small-Cell Lung Cancer: A Systematic Review and Meta-Analysis by Xiaohan Qian, Mengjiao Fu, Jing Zheng, Jianya Zhou, Jianying Zhou

Get full text

Stability Analysis of Low-Carbon Technology Innovation Cooperation under a Reward and Punishment Mechanism by Min Wang, Runxin He, Kai Ren, Youshi He, Jianya Zhou

Get full text

Prognostic Nomogram for Predicting Survival in Asian Patients With Small‐Cell Lung Cancer: A Comprehensive Population‐Based Study and External Verification by Yuanli Xia, Jingjing Qu, Yufang Wang, Yanping Zhu, Jianying Zhou, Jianya Zhou

Get full text

Priming with LSD1 inhibitors promotes the persistence and antitumor effect of adoptively transferred T cells by Fengqi Qiu, Peishan Jiang, Guiheng Zhang, Jie An, Kexin Ruan, Xiaowen Lyu, Jianya Zhou, Wanqiang Sheng

Get full text

A Prediction Model for ROS1-Rearranged Lung Adenocarcinomas based on Histologic Features. by Jianya Zhou, Jing Zhao, Jing Zheng, Mei Kong, Ke Sun, Bo Wang, Xi Chen, Wei Ding, Jianying Zhou

Get full text

Efficacy and Safety of Anlotinib in EGFR-Positive Patients with Advanced Lung Adenocarcinoma Compared with Chemotherapy: A Retrospective Study by Cuihong Cai BS Med, Qian Shen MM, Jingjing Shao MD, Jingjing Qu MD, Shuangshuang Zhou MD, Jianya Zhou MD

Get full text

CD57-positive CD8 + T cells define the response to anti-programmed cell death protein-1 immunotherapy in patients with advanced non-small cell lung cancer by Wenjia Sun, Fengqi Qiu, Jing Zheng, Liangjie Fang, Jingjing Qu, Shumeng Zhang, Nan Jiang, Jianying Zhou, Xun Zeng, Jianya Zhou

Get full text

CXCR6-positive circulating mucosal-associated invariant T cells can identify patients with non-small cell lung cancer responding to anti-PD-1 immunotherapy by Jingjing Qu, Binggen Wu, Lijun Chen, Zuoshi Wen, Liangjie Fang, Jing Zheng, Qian Shen, Jianfu Heng, Jianya Zhou, Jianying Zhou

Get full text

Crizotinib in patients with anaplastic lymphoma kinase-positive advanced non-small cell lung cancer versus chemotherapy as a first-line treatment by Jianya Zhou, Jing Zheng, Xiaochen Zhang, Jing Zhao, Yanping Zhu, Qian Shen, Yuehong Wang, Ke Sun, Zeying Zhang, Zhijie Pan, Yihong Shen, Jianying Zhou

Get full text

Mefatinib as first-line treatment of patients with advanced EGFR-mutant non-small-cell lung cancer: a phase Ib/II efficacy and biomarker study by Pingli Wang, Yuping Li, Dongqing Lv, Lingge Yang, Liren Ding, Jianya Zhou, Wei Hong, Youfei Chen, Dongqing Zhang, Susu He, Jianying Zhou, Kai Wang

Get full text

CD161+CD127+CD8+ T cell subsets can predict the efficacy of anti-PD-1 immunotherapy in non-small cell lung cancer with diabetes mellitus by Jingjing Qu, Yuekang Li, Binggen Wu, Qian Shen, Lijun Chen, Wenjia Sun, Bo Wang, Lixiong Ying, Li Wu, Hong Zhou, Jianya Zhou, Jianying Zhou

Get full text

Josephin domain containing 2 (JOSD2) promotes lung cancer by inhibiting LKB1 (Liver kinase B1) activity by Tao Yuan, Chenming Zeng, Jiawei Liu, Chenxi Zhao, Fujing Ge, Yuekang Li, Meijia Qian, Jiamin Du, Weihua Wang, Yonghao Li, Yue Liu, Xiaoyang Dai, Jianya Zhou, Xueqin Chen, Shenglin Ma, Hong Zhu, Qiaojun He, Bo Yang

Get full text

A pooled analysis of clinical outcome in driver-gene negative non-small cell lung cancer patients with MET overexpression treated with gumarontinib by Yongfeng Yu, Wen Dong, Yanxia Shi, Rong Wu, Qitao Yu, Feng Ye, Chengzhi Zhou, Xiaorong Dong, Xingya Li, Yongsheng Li, Zhen Li, Lin Wu, Yueyin Pan, Hong Shen, Dehua Wu, Zhongyuan Xu, Jinsheng Wu, Nong Xu, Yanru Qin, Aimin Zang, Jingdong Zhang, Jianya Zhou, Xiaotao Zhang, Yanqiu Zhao, Fugen Li, Huizhen Wang, Qi Liu, Zhenyong Han, Jin Li, Shun Lu

Get full text

Gumarontinib in patients with non-small-cell lung cancer harbouring MET exon 14 skipping mutations: a multicentre, single-arm, open-label, phase 1b/2 trialResearch in context by Yongfeng Yu, Jianya Zhou, Xingya Li, Koichi Goto, Xuhong Min, Kazumi Nishino, Jiuwei Cui, Lin Wu, Jun Sakakibara, Yongqian Shu, Xiaorong Dong, Lu Li, Yasuto Yoneshima, Chengzhi Zhou, Xiaoling Li, Yiping Zhang, Dingzhi Huang, Aimin Zang, Wei Zhang, Xiuwen Wang, Li Zhang, Chong Bai, Jian Fang, Lejie Cao, Yanqiu Zhao, Yan Yu, Meiqi Shi, Diansheng Zhong, Fugen Li, Meng Li, Qiuxia Wu, Jun Zhou, Minghui Sun, Shun Lu

Get full text